by Jordana Choucair | Nov 2, 2021 | Opioid/Substance Use Disorders
A superior court judge in California became the first judge to reject government claims that opioid makers should be held responsible for the addiction crisis. The judge ruled that a handful of opioid manufacturers, including Johnson & Johnson, Teva Pharmaceutical...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Eli Lilly and Co. announced that the U.S. government bought 614,000 additional doses of its COVID-19 antibody therapy for $1.29 billion. As part of the agreement, Lilly will supply a minimum of 400,000 doses of bamlanivimab with etesevimab no later than December 31,...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Pfizer said its COVID-19 vaccine brought in $13 billion in sales in the third quarter and boosted its year-end forecast to $36 billion due to global deals for booster shots and broader eligibility for the vaccine. The company said it plans to deliver 2.3 billion doses...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Jeffrey Zients, the White House’s COVID-19 response coordinator, said the federal government has already begun shipping 15 million doses of Pfizer’s COVID-19 vaccine for younger children. Zients said pediatric vaccine rollout will begin “running at full...
by Jordana Choucair | Nov 2, 2021 | D.C. News
Senator Joe Manchin said he would not support President Biden’s revised spending plan without “greater clarity” about its economic effects. Citing “budget gimmicks,” Manchin said that the package’s full price tag could be double the advertised cost if the proposed...
by Jordana Choucair | Nov 2, 2021 | D.C. News
The Biden administration will publish details on COVID-19 vaccine mandate for businesses in the coming days. The mandate will require companies to develop and enforce a mandatory COVID-19 vaccination policy unless they create a plan that gives workers the option to...
Recent Comments